Exchange: NYSE·Updated 07:59 PM EDT
News
all
press releases
Medtronic vs. Intuitive Surgical: Which MedTech Stock Is the Better Buy Right Now?
Key PointsMedtronic has launched new devices that will help further improve its financial results...
Nasdaq News: Markets
More News
ANGO's FY27 Guidance Puts Med Tech Growth and Tariff Risks in Focus
AngioDynamics' fiscal 2027 outlook hinges on Med Tech growth offsetting flat device sales as tariffs, spending and losses pressure margins.
Zacks
ANGO Jumps 33.5% in 3 Months: Can the Rally Keep Going?
AngioDynamics' 33.5% three-month rally rests on Med Tech growth, but valuation, tariffs and negative earnings keep execution risks high.
Zacks
Cresco Labs Inc. (CRLBF) Q2 Earnings and Revenues Top Estimates
Cresco Labs Inc. (CRLBF) delivered earnings and revenue surprises of +300.00% and +4.41%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Medtronic Expands CE Mark Indication For Affera System For Ventricular Arrhythmias Treatment
(RTTNews) - Thursday, Medtronic plc (MDT) announced the expansion of the CE Mark indication for the Affera Mapping and Ablation System with Sphere-9 Catheter to treat ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes...
Nasdaq News: Markets
Medtronic announces expanded CE Mark indication for Affera Mapping and Ablation System and Sphere-9 Catheter for treatment of ventricular arrhythmias
Medtronic announces expanded CE Mark indication for Affera Mapping and Ablation System and Sphere-9 Catheter for treatment of ventricular arrhythmias Medtronic announces expanded CE Mark indication for Affera Mapping and Ablation System and Sphere-9 Catheter for treatment of ventricular arrhythmias...
PR Newswire
I'm Calling It: Medtronic (MDT) Will Soar 40% by the End of 2026
Key PointsMedtronic's stock has slumped over the past five years...
Nasdaq News: Markets
Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?
Boston Scientific's cheaper valuation offers upside, but weaker guidance, share losses, higher debt and delayed catalysts favor patience.
Zacks
Medtronic (MDT) Laps the Stock Market: Here's Why
The latest trading day saw Medtronic (MDT) settling at $86.68, representing a +1.51% change from its previous close.
Zacks
Medtronic PLC (MDT) Is a Trending Stock: Facts to Know Before Betting on It
Medtronic (MDT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Zacks

Advertisement|Remove ads.